7-azaindoles As Inhibitors Of C-jun N-terminal Kinases For The Treatment Of Neurodegenerative Disorders


The present invention relates to novel 3,5-substituted 7-azaindole compounds of formula (I), their use in the inhibition of c-Jun N-terminal kinases, their use in medecine and particularly in the prevention and/or treatment of neurodegenerative disorders related to apoptosis and/or inflammation. The invention also provides processes for manufacture of said compounds, compositions containing them and processes for manufacturing such compositions.

IPC Classifications
Download PDF
Document Preview
Document History
  • Publication: May 19, 2009
  • Application: Jul 28, 2005
    US US 50912805 A
  • Priority: Mar 17, 2003
    GB GB 0301112 W
  • Priority: Jul 25, 2002
    GB GB 0217330 A
  • Priority: Mar 28, 2002
    GB GB 0207491 A

Download Citation

Sign in to the Lens